AG真人官方

STOCK TITAN

Bristol Myers Squibb to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

PRINCETON, N.J.--(BUSINESS WIRE)-- (NYSE: BMY) today announced that the company will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on Monday, September 8, 2025.

The company will take part in a fireside chat beginning at 8:30 a.m. ET.

Investors and the general public are invited to listen to the session by visiting . An archived edition of the session will be available following its conclusion.

About Bristol Myers Squibb: Transforming Patients鈥� Lives Through Science
At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what鈥檚 possible for the future of medicine and the patients we serve. For more information, visit us at and follow us on LinkedIn, , , and .

corporatefinancial-news

Media Relations:

[email protected]



Investor Relations:

[email protected]

Source: Bristol Myers Squibb

Bristol-Myers Squibb Co

NYSE:BMY

BMY Rankings

BMY Latest News

BMY Latest SEC Filings

BMY Stock Data

96.09B
2.03B
0.08%
82.89%
1.52%
Drug Manufacturers - General
Pharmaceutical Preparations
United States
PRINCETON